BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31001351)

  • 1. Inhibition of Cytochrome P450 Activities by
    Yim D; Kim MJ; Shin Y; Lee SJ; Shin JG; Kim DH
    Evid Based Complement Alternat Med; 2019; 2019():2673769. PubMed ID: 31001351
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-evaluation of the antioxidant prenylated flavonoids from the roots of Sophora flavescens.
    Jung HA; Jeong DM; Chung HY; Lim HA; Kim JY; Yoon NY; Choi JS
    Biol Pharm Bull; 2008 May; 31(5):908-15. PubMed ID: 18451517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
    Misaka S; Kawabe K; Onoue S; Werba JP; Giroli M; Tamaki S; Kan T; Kimura J; Watanabe H; Yamada S
    Drug Metab Pharmacokinet; 2013; 28(3):244-9. PubMed ID: 23268924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
    Jung HA; Yoon NY; Kang SS; Kim YS; Choi JS
    J Pharm Pharmacol; 2008 Sep; 60(9):1227-36. PubMed ID: 18718128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogenic Prenylated Flavonoids in
    Nishi K; Imamura I; Hoashi K; Kiyama R; Mitsuiki S
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397194
    [No Abstract]   [Full Text] [Related]  

  • 7. The anti-inflammatory activity of flavonoids and alkaloids from Sophora flavescens alleviates psoriasiform lesions: Prenylation and methoxylation beneficially enhance bioactivity and skin targeting.
    Lin CF; Lin MH; Hung CF; Alshetaili A; Tsai YF; Jhong CL; Fang JY
    Phytother Res; 2024 Apr; 38(4):1951-1970. PubMed ID: 38358770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of prenylated flavonoids from Sophora flavescens against BACE1 and cholinesterases.
    Jung HA; Yokozawa T; Kim BW; Jung JH; Choi JS
    Am J Chin Med; 2010; 38(2):415-29. PubMed ID: 20387235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-allergic prenylated flavonoids from the roots of Sophora flavescens.
    Quan W; Lee HJ; Kim CY; Noh CW; Um BH; Oak MH; Kim KM
    Planta Med; 2008 Feb; 74(2):168-70. PubMed ID: 18219599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inductive profiles of hepatic cytochrome P450s by the extracts of Sophora flavescens in male and female C57BL/6JNarl mice.
    Ueng YF; Chen CC; Tsai CC; Soucek P
    J Ethnopharmacol; 2009 Dec; 126(3):437-46. PubMed ID: 19772910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kushenol C from
    Wang F; Shin JY; Kang ES; Kim JH; Jang SI; Cho BO
    Heliyon; 2023 Dec; 9(12):e22804. PubMed ID: 38090015
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of flavonoids from Sophora flavescens to the rat uterine estrogen receptor.
    Hillerns PI; Wink M
    Planta Med; 2005 Nov; 71(11):1065-8. PubMed ID: 16320211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4.
    Renwick AB; Lewis DF; Fulford S; Surry D; Williams B; Worboys PD; Cai X; Wang RW; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2001 Apr; 31(4):187-204. PubMed ID: 11465405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Jeong HU; Lee HS
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside.
    Sun DX; Lu JC; Fang ZZ; Zhang YY; Cao YF; Mao YX; Zhu LL; Yin J; Yang L
    Phytother Res; 2010 Nov; 24(11):1670-5. PubMed ID: 21031626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
    Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T
    Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.